glp-1 management platform startups 5 Startups Looking to Compete in the Obesity Space Digital health companies are launching

Found focuses mainly on compounded medications

Association between completed suicide and bipolar disorder: a systematic review of the literature

Id always thought GLP-1s (like Ozempic) were only for people with a lot of weight to lose

Participants who received the three different doses all lost more weight than a placebo group, which lost an average of more than 2% of body weight

[DOI] [PMC free article] [PubMed] [Google Scholar] 97.Barrera JG, et al

In the semaglutide group, 569 out of 8803 patients (6.5%) experienced a primary cardiovascular end-point event, compared to 701 out of 8801 patients (8.0%) in the placebo group (hazard ratio, 0.80